The world is facing a renewed battle against cholera, a deadly disease that has been lurking in the shadows for too long. But now, the tide is turning.
The World Health Organization (WHO) has announced a bold move: the restart of preventive cholera vaccinations after a nearly four-year hiatus. This decision comes as a ray of hope for millions, especially in regions where cholera outbreaks have been devastating.
The pause in vaccinations since 2022 was due to a critical vaccine shortage, which forced health authorities to react to outbreaks rather than proactively prevent them. The shortage was a result of surging demand, leaving the global stockpile depleted. During this time, countries battling cholera outbreaks were left with limited resources, requesting far more vaccines than were available.
However, the tide is turning. The WHO, alongside GAVI and the United Nations Children's Fund, have announced a significant boost in the global stockpile, reaching nearly 70 million doses in 2025. This increase allows for a strategic shift from reactive to preventive measures, a crucial step in the fight against cholera.
Here's where it gets controversial: The WHO's recommendation to switch to a one-dose vaccination strategy, instead of the standard two doses, sparked debates. While this decision was made due to the shortage, the WHO now states that the one-dose strategy will remain, with two-dose campaigns considered only in specific cases. This approach raises questions about the long-term effectiveness of the vaccination program.
Cholera, a waterborne bacterial disease, thrives in conditions of poverty, conflict, and climate crises. These factors often lead to the destruction of health facilities, limited access to clean water, and flooding, which can rapidly spread the disease. The recent flooding in southern Africa, affecting around 700,000 people, is a stark reminder of the urgent need for preventive measures.
And this is the part most people miss: Climate change is not just an environmental issue; it's a health emergency. WHO has acknowledged that climate change has aggravated the global cholera upsurge since 2021, leading to more frequent and severe outbreaks. This connection highlights the complex interplay between environmental factors and public health.
The initial allocation of 20 million doses is already making an impact. Mozambique, Congo, and Bangladesh are receiving substantial amounts, with Mozambique getting 3.6 million doses, Congo 6.1 million, and Bangladesh 10.3 million. These countries, among others, are now better equipped to protect their populations from cholera.
The WHO's Director-General, Tedros Adhanom Ghebreyesus, emphasized the importance of this shift, stating, 'Global vaccine shortages forced us into a reactive mode, but we are now breaking that cycle.'
Cholera's impact is staggering. In 2025, the WHO reported over 600,000 cases and nearly 7,600 deaths, with a concerning rise in fatalities despite a slight decline in overall cases. These numbers serve as a stark reminder of the disease's relentless grip.
As the world takes a step forward in the fight against cholera, the question remains: Will this renewed effort be enough to curb the disease's devastating impact? The battle against cholera is far from over, and the strategies employed will undoubtedly spark further discussions and debates. What are your thoughts on this global health challenge and the measures being taken?
